Neuroderm Ltd Ord Sh (NDRM)
38.85 -0.05 (-0.13%) 10/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Tue, Oct 17th, 2017
Results
download Want to compare other data? Select Fields| Symbol | NDRM | ELVN | HROW | ||
| Company | Neuroderm Ltd Ord Sh | Enliven Therapeutics Inc | Harrow Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.90 | 20.64 | 27.75 | ||
| High | 38.95 | 21.05 | 28.35 | ||
| Low | 38.85 | 20.55 | 27.59 | ||
| Last | 38.85 | 20.83 | 28.09 | ||
| Change | -0.05 | -0.09 | -0.11 | ||
| % Change | -0.13% | -0.43% | -0.39% | ||
| Volume | 200,900 | 66,535 | 196,648 | ||
| 20-Day Average Volume | 252,855 | 202,122 | 545,140 | ||
| Previous Close | 38.90 | 20.92 | 28.09 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.89 | 20.63 | 25.64 | ||
| 20-Day Raw Stochastic | 0.00% | 50.95% | 63.54% | ||
| 20-Day Relative Strength | 65.29% | 46.28% | 48.94% | ||
| Weighted Alpha | +75.10 | -8.67 | +32.08 | ||
| Today's Opinion | N/A | 100% Sell | 72% Sell | ||
| Previous Opinion | N/A | 88% Sell | 72% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 10/10/17 | -0.92% since 03/14/25 | +21.14% since 03/14/25 | ||
| Low | 38.85 on 10/17/17 | 19.98 on 03/17/25 | 22.84 on 03/17/25 | ||
| High | 38.95 on 10/17/17 | 21.34 on 03/20/25 | 31.74 on 03/18/25 | ||
| 1-Month | |||||
| %Chg | unch since 09/15/17 | -5.73% since 02/21/25 | -3.71% since 02/21/25 | ||
| Low | 38.80 on 09/19/17 | 18.67 on 03/04/25 | 21.14 on 03/10/25 | ||
| High | 38.95 on 10/17/17 | 22.36 on 03/06/25 | 31.74 on 03/18/25 | ||
| 3-Month | |||||
| %Chg | +24.32% since 07/17/17 | -8.54% since 12/20/24 | -18.54% since 12/20/24 | ||
| Low | 30.70 on 07/18/17 | 18.67 on 03/04/25 | 21.14 on 03/10/25 | ||
| High | 38.95 on 10/17/17 | 25.37 on 01/03/25 | 37.47 on 01/03/25 | ||
| 6-Month | |||||
| %Chg | +46.05% since 04/17/17 | -11.38% since 09/20/24 | -38.08% since 09/20/24 | ||
| Low | 20.00 on 05/30/17 | 18.67 on 03/04/25 | 21.14 on 03/10/25 | ||
| High | 38.95 on 10/17/17 | 30.03 on 10/18/24 | 59.23 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,023,698 | 1,025,164 | 1,000,425 | ||
| Shares Outstanding, K | 26,350 | 49,004 | 35,615 | ||
| Annual Sales | 0 | 0 | 130,190,000 | ||
| Annual Net Income | -32,500,000 | -89,020,000 | -24,410,000 | ||
| Last Quarter Sales | N/A | 0 | 49,260,000 | ||
| Last Quarter Net Income | N/A | -23,180,000 | -4,220,000 | ||
| 60-Month Beta | 0.77 | 1.04 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 05/11/17 | -0.46 on 03/13/25 | -0.12 on 11/13/24 | ||
| Latest Earnings Date | 11/09/17 | 05/13/25 | 03/17/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||